The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Khobreh, Mohammad
    Managing Director born in September 1988
    Individual (3 offsprings)
    Officer
    2023-07-21 ~ now
    OF - Director → CIF 0
  • 2
    Sando, Gregg Stephen
    Investor born in February 1958
    Individual (2 offsprings)
    Officer
    2023-07-21 ~ now
    OF - Director → CIF 0
  • 3
    Dr Timothy Mark Newton
    Born in April 1988
    Individual (1 offspring)
    Person with significant control
    2023-11-07 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 4
    Ajetunmobi, Ayokunmi Luke
    Investment Professional born in November 1989
    Individual (1 offspring)
    Officer
    2024-04-22 ~ now
    OF - Director → CIF 0
Ceased 5
  • 1
    Sturt, Gemma Elizabeth Olivia
    Investment Professional born in February 1997
    Individual (1 offspring)
    Officer
    2023-07-21 ~ 2024-04-22
    OF - Director → CIF 0
  • 2
    Newton, Timothy Mark, Dr.
    Scientist born in April 1988
    Individual (1 offspring)
    Officer
    2018-10-01 ~ 2023-07-21
    OF - Director → CIF 0
    Dr. Timothy Mark Newton
    Born in April 1988
    Individual (1 offspring)
    Person with significant control
    2018-10-01 ~ 2023-07-21
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    Dr Timothy Mark Newton
    Born in April 1988
    Individual (1 offspring)
    Person with significant control
    2023-07-21 ~ 2023-08-23
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 3
    Do O, Nuno Francisco Vilhena Fernandes Madeira, Dr
    Company Director born in May 1985
    Individual
    Officer
    2022-12-05 ~ 2024-05-31
    OF - Director → CIF 0
  • 4
    Emami-shahri, Nia, Dr
    Scientist born in June 1985
    Individual (1 offspring)
    Officer
    2023-01-03 ~ 2024-10-31
    OF - Director → CIF 0
  • 5
    TCPI ASSET 1 LIMITED - 2013-04-10
    Moneta, Babraham Research Campus, Babraham, Cambridge, United Kingdom
    Active Corporate (4 parents, 32 offsprings)
    Equity (Company account)
    805,306 GBP2018-04-30
    Officer
    2020-05-01 ~ 2023-08-22
    PE - Secretary → CIF 0
parent relation
Company in focus

BASTION THERAPEUTICS LIMITED

Previous names
REFLECTION THERAPEUTICS LIMITED - 2023-08-08
TMN THERAPEUTICS LIMITED - 2020-07-10
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
23,147 GBP2024-03-31
1,218 GBP2023-03-31
Debtors
Current
115,994 GBP2024-03-31
13,146 GBP2023-03-31
Non-current
3,400 GBP2024-03-31
0 GBP2023-03-31
Cash at bank and in hand
323,315 GBP2024-03-31
8,196 GBP2023-03-31
Creditors
Non-current
0 GBP2024-03-31
-18,982 GBP2023-03-31
Net Assets/Liabilities
411,644 GBP2024-03-31
-33,703 GBP2023-03-31
Equity
Called up share capital
196 GBP2024-03-31
138 GBP2023-03-31
Share premium
1,273,664 GBP2024-03-31
341,621 GBP2023-03-31
Retained earnings (accumulated losses)
-862,216 GBP2024-03-31
-375,462 GBP2023-03-31
Equity
411,644 GBP2024-03-31
-33,703 GBP2023-03-31
Average Number of Employees
42023-04-01 ~ 2024-03-31
32022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
28,934 GBP2024-03-31
6,579 GBP2023-03-31
Computers
5,890 GBP2024-03-31
2,228 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
34,824 GBP2024-03-31
8,807 GBP2023-03-31
Property, Plant & Equipment - Disposals
Plant and equipment
0 GBP2023-04-01 ~ 2024-03-31
Computers
-403 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Disposals
-403 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
9,205 GBP2024-03-31
6,214 GBP2023-03-31
Computers
2,472 GBP2024-03-31
1,375 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
11,677 GBP2024-03-31
7,589 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
2,991 GBP2023-04-01 ~ 2024-03-31
Computers
1,130 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
4,121 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Plant and equipment
0 GBP2023-04-01 ~ 2024-03-31
Computers
-33 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-33 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
19,729 GBP2024-03-31
365 GBP2023-03-31
Computers
3,418 GBP2024-03-31
853 GBP2023-03-31
Amount of corporation tax that is recoverable
Current
6,623 GBP2024-03-31
6,623 GBP2023-03-31
Other Debtors
Current
109,371 GBP2024-03-31
6,523 GBP2023-03-31
Trade Creditors/Trade Payables
Current
46,180 GBP2024-03-31
22,669 GBP2023-03-31
Other Creditors
Current
8,032 GBP2024-03-31
13,399 GBP2023-03-31
Non-current
0 GBP2024-03-31
18,982 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10,774,000 shares2024-03-31
Par Value of Share
Class 1 ordinary share
0.00001 GBP2023-04-01 ~ 2024-03-31
Nominal value of allotted share capital
Class 1 ordinary share
108 GBP2023-04-01 ~ 2024-03-31
138 GBP2022-04-01 ~ 2023-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
8,796,000 shares2024-03-31
Par Value of Share
Class 2 ordinary share
0.00001 GBP2023-04-01 ~ 2024-03-31
Nominal value of allotted share capital
Class 2 ordinary share
88 GBP2023-04-01 ~ 2024-03-31
0 GBP2022-04-01 ~ 2023-03-31
  • BASTION THERAPEUTICS LIMITED
    Info
    REFLECTION THERAPEUTICS LIMITED - 2023-08-08
    TMN THERAPEUTICS LIMITED - 2020-07-10
    Registered number 11597069
    35 Ballards Lane, London N3 1XW
    Private Limited Company incorporated on 2018-10-01 (6 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-30
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.